The title salts, C 8 H 13 N 4 + ÁCl À , (I), and C 8 H 13 N 4 + ÁNO 3 À , (II), contain linked pyridinium-piperazine heterocycles. In both salts, the piperazine ring adopts a chair conformation with protonation at the N atom not linked to the other ring. In the crystal of (I), weak N-HÁ Á ÁCl interactions are observed, leading to zigzag chains along [100] . In the crystal of (II), both H atoms on the NH 2 + group form bifurcated N-HÁ Á Á(O,O) hydrogen bonds. Weak C-HÁ Á ÁO interactions are also observed. These bonds collectively link the components into infinite chains along [100].
Chemical context
Pyrimidine-containing compounds exhibit various biological activities (Goldmann & Stoltefuss, 1991) and related fused heterocycles are unique classes of heterocyclic compounds that exhibit a broad spectrum of biological activities such as anticancer (Amin et al., 2009; Pandey et al., 2004) , antiviral (Ibrahim & El-Metwally, 2010) , antibacterial (Kuyper et al., 1996) and anti-oxidant (Padmaja et al., 2009) , antidepressant (Kim et al., 2010) and possess anti-inflammatory effects (Clark et al., 2007) . In addition, several piperazine derivatives have reached the stage of clinical application; among the known drugs that are used to treat anxiety is a pyrimidinylpiperazinyl compound, buspirone (trade name BuSpar 1 ) (Tollefson et al., 1991) . Our research group has published a number of papers on incorporated heterocyclic ring structures, viz. imatinibium dipicrate (Jasinski et al., 2010) , 1-(2-hydroxyethyl)-4-[3-(2-trifluoromethyl-9H-thioxanthen-9-ylidene)propyl]piperazine-1,4-diium dichloride, which is the dihydrochloride salt of flupentixol (Siddegowda et al., 2011a) and opipramolium fumarate (Siddegowda et al., 2011b) . Other related crystal structures are 4-(pyrimidin-2-yl)piperazin-1-ium (E)-3-carboxyprop-2-enoate (Yamuna et al., 2014a) , flupentixol tartarate and enrofloxacinium oxalate (Yamuna et al., 2014b,c) . As part of our ongoing studies in this area, we report herein the crystal structures of the title salts, (I) and (II).
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Structural commentary
The structure of (I) and its atom numbering are shown in Fig. 1 . It consists of a pyrimidylpiperazine cation joined by the C1/N3 atoms of each unit and a chloride anion. The C1-N3 bond is 1.373 (3) Å long, which compares favorably with similar ionic structures containing this cation [1.369 (3) (Yamuna et al., 2014a) , and 1.36 (6) and 1.37 (1) Å (Ding et al., 2014) ]. The N3/C5/C6/N4/C7/C8 piperazine unit adopts a slightly distorted chair conformation with protonation at the N4 nitrogen atom. The structure of (II) and its atom numbering are shown in Fig. 2 . Similarly, it consists of a pyrimidylpiperazine cation joined by the C1/N3 atoms of each unit and a nitrate anion. The C1-N3 bond is 1.369 (3) Å , also in the range of the related structures described above. The N3/ C5/C6/N4/C7/C8 piperazine unit also adopts a slightly distorted chair conformation with protonation at the N4 atom.
Supramolecular features
In the crystal of (I), N4-H4AÁ Á ÁCl1 and N4-H4BÁ Á ÁCl1 interactions are observed between pyrimidylpiperazine cations and chloride anions, forming zigzag chains along [100] ( Fig. 3 and Table 1 ). In the crystal of (II), both of the H atoms on the N4 atom of the pyrimidylpiperazine cation are bifurcated, forming N-HÁ Á Á(O,O) hydrogen bonds ( Fig. 4 and Table 2 ). Additional C-HÁ Á ÁO interactions between the pyrimidyl unit and the nitrate anion are present which, in concert with the N-HÁ Á ÁO hydrogen bonds between the piperazine group and nitrate anions, form infinite chains along [100]. Table 1 for details). H atoms not involved in hydrogen bonding have been omitted for clarity. Table 2 for details). H atoms not involved in hydrogen bonding have been omitted for clarity.
Database survey
tures containing the 4-(pyrimidin-2-yl)piperazin-1-ium cation similar to the structures reported here. These include the salts of 4-(pyrimidin-2-yl)piperazin-1-ium 3-carboxyprop-2-enoate (Yamuna et al. 2014a) , 4-(pyrimidin-2-yl)piperazin-1-ium hydrogen d-tartrate monohydrate (Ding et al., 2014) and 4-(pyrimidin-2-yl)piperazin-1-ium hydrogen l-tartrate monohydrate (Ding et al. 2014) . The 3-carboxyprop-2-enoate complex crystallizes in space group P2 1 /c while the two hydrogen (D and L)-tartrate monohydrate salts both crystallize in P2 1 2 1 2 1 . In comparison, title salt (I) crystallizes in P2 1 2 1 2 1 while (II) crystallizes in space group P2 1 /c. In addition, as a related observation, 109 structures containing the pyrimidine-piperazine unit were also identified in this search. Some of these include, uniquely, the 4-(pyrimidin-2-yl)piperazin-1-yl unit itself. These include 1-[4-(pyrimidin-2-yl)piper- (Bielenica et al., 2011) .
Synthesis and crystallization
For the preparation of title salt (I), a mixture of 1-(pyrimidin-2-yl)piperazine (0.2 g) and concentrated hydrochloric acid (5 ml) was stirred well over a magnetic stirrer at room temperature for 10 min and then warmed at 313 K for another 10 min. A white precipitate was obtained, which was dried in research communications Table 1 Hydrogen-bond geometry (Å , ) for (I). Table 2 Hydrogen-bond geometry (Å , ) for (II). 
the open air overnight and then dissolved in hot dimethyl sulfoxide solvent. After few days, colourless blocks were obtained on slow evaporation (m.p. above 563 K). For the preparation of title salt (II), a mixture of 1-(pyrimidin-2-yl)piperazine, from Sigma-Aldrich (0.2 g), and concentrated nitric acid (5 ml) was stirred well over a magnetic stirrer at room temperature for 10 min. A white precipitate was obtained immediately, which was dried in the open air overnight and then dissolved in water. After a few days, colourless blocks were obtained on slow evaporation (m.p. 463-470 K).
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 3 . In both (I) and (II), all of the H atoms were placed in their calculated positions and then refined using a riding model with C-H bond lengths of 0.93 (CH) or 0.97 Å (CH 2 ) and N-H bond lengths of 0.97 Å . Isotropic displacement parameters for these atoms were set at 1.2U eq (CH,CH 2 ,NH). 
Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. Extinction coefficient: 0.0099 (14) Special details Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (
N3-C5-H5A 109.6 N1-C2-C3-C4 −0.8 (4) C4-N2-C1-N1 −0.6 (4) N3-C5-C6-N4 55.8 (3) C4-N2-C1-N3 −178.9 (3) N4-C7-C8-N3 −54.5 (3) C5-N3-C1-N1 172.5 (2) C1-N1-C2-C3 1.0 (4) C5-N3-C1-N2 −9.0 (4) C1-N2-C4-C3 0.8 (4) C5-N3-C8-C7 55.2 (3) C1-N3-C5-C6 151.9 (2) C6-N4-C7-C8 57.4 (3) C1-N3-C8-C7 −152.4 (2) C7-N4-C6-C5 −58.1 (3) C2-N1-C1-N2 −0.3 (4) C8-N3-C1-N1 21.8 (4) C2-N1-C1-N3 178.0 (2) C8-N3-C1-N2 −159.8 (2) C2-C3-C4-N2 −0.2 (5) C8-N3-C5-C6 −55.8 (3)
